期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

原发性骨髓增生异常综合征伴8号染色体三体的预后意义 被引量：1

原文传递
导出
摘要 我们采用常规细胞遗传学分析和荧光原位杂交（FISH）技术，在435例成人原发性骨髓增生异常综合征（MDS）患者中发现71例伴8号染色体三体（＋8）异常。我们对这部分具有＋8异常的病例与正常核型、20q-、-7／7q-、复杂核型患者进行比较，探讨＋8异常在MDS中的预后意义。
机构地区 上海市中美联合白血病协作组
出处 《中华血液学杂志》 CAS CSCD 北大核心 2009年第8期556-558,共3页 Chinese Journal of Hematology
关键词 原发性骨髓增生异常综合征 8号染色体三体 预后意义 细胞遗传学分析 荧光原位杂交 MDS 核型
分类号 R135.12 [医药卫生—劳动卫生] R394 [医药卫生—医学遗传学]
  • 相关文献

参考文献10

  • 1Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
  • 2Pedersen B. MDS and AML with trisomy 8 as the sole chromosome aberration show different sex ratios and prognostic profiles: a study of 115 published cases. Am J Hematol, 1997,56 : 224-229.
  • 3邱镜滢,赖悦云,柴晔,张艳,师岩,何琦,党辉,陆道培.306例骨髓增生异常综合征染色体核型的研究[J].中国实验血液学杂志,2004,12(4):455-459. 被引量：32
  • 4Campbell LJ, Garson OM. The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia, 1994, 8: 67-71.
  • 5Liu YC, Ito Y, Hsiao HH, et al. Risk factor analysis in myelodysplastic syndrome patients with del (20q): prognosis revisited. Cancer Genet Cytogenet, 2006, 171 : 9-16.
  • 6Douet-Guilbert N, Basinko A, Morel F, et al. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosomenegative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions. Ann Hematol, 2008, 87 : 537-544.
  • 7Kantarjian H, O' Brien S, Ravandi F, et al. Proposal for a new risk mode/in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer, 2008, 113 : 1351-1361.
  • 8Knipp S, Hildebrand B, Kundgen A, et al. Intensive chemotherapy is not recommended for patients aged > 60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes. Cancer, 2007,110:345-352.
  • 9Bernasconi P, Klersy C, Boni M, et al. Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institu- tion. Leukemia, 2005, 19: 1424-1431.
  • 10Pozdnyakova O, Miron PM, Tang G, et al. Cytogenetie abnormalities in a series of 1029 patients with primary myelodysplastie syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer, 2008, 113: 3331- 3340.

二级参考文献3

共引文献31

同被引文献15

  • 1Schanz J, Tüchler H, Solé F, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge[J]. J Clin Oncol, 2012, 30(8):820-829.
  • 2Bernasconi P, Klersy C, Boni M, et al. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes[J]. Br J Haematol, 2007, 137(3):193-205.
  • 3Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes[J]. J Clin Oncol, 2007, 25(23): 3503-3510.
  • 4Brunning RD, Orazi A, Germing U, et al. Myelodysplastic syndromes//Swerdlow SH, Campo E, Harris N, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M]. Lyon: IARC, 2008:87-107.
  • 5Schanz J, Steidl C, Fonatsch C, et al. Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system[J]. J Clin Oncol, 2011, 29(15):1963-1970.
  • 6Mallo M, Lu?o E, Sanzo C, et al. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome[J]. Leuk Res, 2011, 35(6):834-836.
  • 7Solé F, Espinet B, Sanz GF, et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espa?ol de Citogenética Hematológica[J]. Br J Haematol, 2000, 108(2): 346-356.
  • 8Haase D, Germing U, Schanz J, et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients[J]. Blood, 2007, 110(13): 4385-4395.
  • 9Paulsson K, Johansson B. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes[J]. Pathol Biol, 2007, 55(1): 37-48.
  • 10Mitelman F, Johansson B, Mertens FE. Mitelman database of chromosome aberrations and gene fusions in cancer[J]. 2011. http://cgap.nci.nih.gov/Chromosomes/Mitelman.

引证文献1

二级引证文献19

中华血液学杂志
2009年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部